Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...

Drugs made with iPS, or induced pluripotent stem cells, will be used to treat patients with severe heart failure and Parkinson’s disease.

The earliest they are likely to become available is around summer, after drug pricing has been finalized. These products will be covered by the public health insurance system. The out-of-pocket burden ...

Japan's health ministry panel on Thursday approved the commercialization of two regenerative medicine products prepared from iPS cell ...

A Japanese health ministry expert panel is to discuss whether to endorse two products using iPS cells. The treatments are for heart disease and Parkinson's.

On February 19, an expert panel at the Ministry of Health, Labor and Welfare conditionally endorsed the manufacturing ...

A Japanese health ministry panel has endorsed two products using iPS cells, paving the way for the world's first practical ...

Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

Twenty years have passed since Kyoto University Prof. Shinya Yamanaka succeeded in creating induced pluripotent stem (iPS) cells for the first time anywhere in the world. It is great news that the ...

A health ministry panel on Thursday sanctioned the conditional production and sale, for a limited period, of two regenerative pharmaceutical products that use induced pluripotent stem (iPS) cells to ...

Ceres Power seems ideally positioned to capitalize on opportunities arising from a booming data center sector. Read here for more on CPWHF stock.

A health ministry panel has conditionally approved, for a limited time, two regenerative medical products derived from induced pluripotent stem (iPS) cells, a key milestone in the possible wider use ...